Latest News

Alzheimer's Disease Research

A promising new treatment for individuals suffering from stroke, concussion, and traumatic brain injury, known risk factors for dementia, has received approval from the U.S. Food & Drug Administration to move into Phase 2 clinical trials. Learn more.

Mar 28, 2024
Alzheimer's Disease Research

Learn how our funded scientists are advancing new ways of diagnosing Alzheimer’s disease earlier and more accurately.

Mar 28, 2024
Alzheimer's Disease Research

Alzheimer’s Disease Research, a BrightFocus Foundation program, joined over 4,500 scientists, physicians, and industry leaders from 70 countries at the annual International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) in Lisbon, Portugal. Read our key takeaways.

 

Mar 11, 2024
Alzheimer's Disease Research

The company behind the first-of-its-kind blood-based screening test for Alzheimer’s disease—rooted in pivotal early BrightFocus support—has received a $15 million investment that will broaden access to the blood test for patients and doctors.

Mar 11, 2024
Alzheimer's Disease Research

A National Institute on Aging senior investigator breaks down amyloid trials: what went wrong and what must come next.

Mar 6, 2024
Alzheimer's Disease Research

Immune cells undergo non-inherited genetic changes that are associated with higher Alzheimer’s risk.

Feb 28, 2024
BrightFocus Foundation

Brightfocus supports a groundbreaking $28M investment by the Canadian Institutes of Health Research to bolster early-career health researchers from historically under-recognized groups.

Feb 28, 2024
Macular Degeneration Research

BrightFocus President and CEO Stacy Pagos Haller spoke with WebMD about the latest breakthroughs in macular degeneration research.

Feb 23, 2024
Alzheimer's Disease Research

A new study asks the question: what if we could reverse the damage caused by Alzheimer’s disease-related proteins like tau? Learn more.

Feb 13, 2024
BrightFocus Foundation

Newly released research portfolios highlight the 276 biomedical research projects funded by BrightFocus Foundation across 16 countries to defeat Alzheimer’s disease, macular degeneration, and glaucoma. 

Feb 2, 2024